Psychoneuroendocrinology
Volume 33, Issue 8 , Pages 1132-1138 , September 2008

Women with polycystic ovary syndrome are often depressed or anxious—A case control study

  • Mattias Månsson

      Affiliations

    • Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
    • Corresponding Author InformationCorresponding author at: Karolinska Institutet, Department of Clinical Neuroscience, Section of Psychiatry S:t Göran, SE-112 81, Stockholm, Sweden. Tel.: +46 8 51770221; fax: +46 8 303706.
    • ,
  • Jan Holte

      Affiliations

    • Carl von Linné Clinic, Uppsala, Sweden
    • ,
  • Kerstin Landin-Wilhelmsen

      Affiliations

    • Department of Medicine, Sahlgrenska University Hospital, Göteborg, Sweden
    • ,
  • Eva Dahlgren

      Affiliations

    • Department of Gynecology and Obstetrics, Sahlgrenska University Hospital, Göteborg, Sweden
    • ,
  • Anette Johansson

      Affiliations

    • Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
    • ,
  • Mikael Landén

      Affiliations

    • Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden

Received 14 April 2008 ,Revised 4 June 2008 ,Accepted 5 June 2008.

References 

  1. American Psychiatric Association . DSM-IV: Diagnostic and Statistical Manual of Mental Disorders. 4th edition. American Psychiatric Publishing; 1994;
  2. Anderson SE, Cohen P, Naumova EN, Jacques PF, Must A. Adolescent obesity and risk for subsequent major depressive disorder and anxiety disorder: prospective evidence. Psychosom. Med. 2007;69:740–747
  3. Baischer W, Koinig G, Hartmann B, Huber J, Langer G. Hypothalamic-pituitary-gonadal axis in depressed premenopausal women: elevated blood testosterone concentrations compared to normal controls. Psychoneuroendocrinology. 1995;20:553–559
  4. Balestrieri M, Baldacci S, Bellomo A, Bellantuono C, Conti L, Perugi G, et al. Clinical vs. structured interview on anxiety and affective disorders by primary care physicians. understanding diagnostic discordance. Epidemiol. Psichiatr. Soc. 2007;16:144–151
  5. Barnard L, Ferriday D, Guenther N, Strauss B, Balen AH, Dye L. Quality of life and psychological well being in polycystic ovary syndrome. Hum. Reprod. 2007;22:2279–2286
  6. Bruce-Jones W, Zolese G, White P. Polycystic ovary syndrome and psychiatric morbidity. J. Psychosom. Obstet. Gynaecol. 1993;14:111–116
  7. Chang RJ. The reproductive phenotype in polycystic ovary syndrome. Nat. Clin. Pract. Endocrinol. Metab. 2007;3:688–695
  8. Chen TH, Chang SP, Tsai CF, Juang KD. Prevalence of depressive and anxiety disorders in an assisted reproductive technique clinic. Hum. Reprod. 2004;19:2313–2318
  9. Ching HL, Burke V, Stuckey BG. Quality of life and psychological morbidity in women with polycystic ovary syndrome: body mass index, age and the provision of patient information are significant modifiers. Clin. Endocrinol. (Oxf.). 2007;66:373–379
  10. Cotrufo P, Monteleone P, d’Istria M, Fuschino A, Serino I, Maj M. Aggressive behavioral characteristics and endogenous hormones in women with Bulimia nervosa. Neuropsychobiology. 2000;42:58–61
  11. Cwikel J, Gidron Y, Sheiner E. Psychological interactions with infertility among women. Eur. J. Obstet. Gynecol. Reprod. Biol. 2004;117:126–131
  12. Dumoulin SC, de Glisezinski I, Saint-Martin F, Jamrozik SI, Barbe P, Thouvenot JP, et al. Hormonal changes related to eating behavior in oligomenorrheic women. Eur. J. Endocrinol. 1996;135:328–334
  13. Dunaif A. Adrenal disorders and polycystic ovary syndrome. Horm. Res. 1992;37:39–44
  14. Dunaif A, Segal KR, Futterweit W, Dobrjansky A. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes. 1989;38:1165–1174
  15. Elsenbruch S, Hahn S, Kowalsky D, Offner AH, Schedlowski M, Mann K, et al. Quality of life, psychosocial well-being, and sexual satisfaction in women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 2003;88:5801–5807
  16. Franks S. Polycystic ovary syndrome. N. Engl. J. Med. 1995;333:853–861
  17. Franks S, McCarthy MI, Hardy K. Development of polycystic ovary syndrome: involvement of genetic and environmental factors. Int. J. Androl. 2006;29:278–285(discussion 286–290)
  18. Goodarzi MO, Azziz R. Diagnosis, epidemiology, and genetics of the polycystic ovary syndrome. Best Pract. Res. Clin. Endocrinol. Metab. 2006;20:193–205
  19. Gorwood P. Generalized anxiety disorder and major depressive disorder comorbidity: an example of genetic pleiotropy?. Eur. Psychiatry. 2004;19:27–33
  20. Goudas VT, Dumesic DA. Polycystic ovary syndrome. Endocrinol. Metab. Clin. North Am. 1997;26:893–912
  21. Hashimoto DM, Schmid J, Martins FM, Fonseca AM, Andrade LH, Kirchengast S, et al. The impact of the weight status on subjective symptomatology of the polycystic ovary syndrome: a cross-cultural comparison between Brazilian and Austrian women. Anthropol. Anz. 2003;61:297–310
  22. Heo M, Pietrobelli A, Fontaine KR, Sirey JA, Faith MS. Depressive mood and obesity in US adults: comparison and moderation by sex, age, and race. Int. J. Obes (Lond.). 2006;30:513–519
  23. Hollinrake E, Abreu A, Maifeld M, Van Voorhis BJ, Dokras A. Increased risk of depressive disorders in women with polycystic ovary syndrome. Fertil. Steril. 2007;87:1369–1376
  24. Holte J. Polycystic ovary syndrome and insulin resistance: thrifty genes struggling with over-feeding and sedentary life style?. J. Endocrinol. Invest. 1998;21:589–601
  25. Hughes C, Elgasim M, Layfield R, Atiomo W. Genomic and post-genomic approaches to polycystic ovary syndrome—progress so far: mini review. Hum. Reprod. 2006;21:2766–2775
  26. Jahanfar S, Eden JA, Nguyent TV. Bulimia nervosa and polycystic ovary syndrome. Gynecol. Endocrinol. 1995;9:113–117
  27. Jahanfar S, Maleki H, Mosavi AR. Subclinical eating disorder, polycystic ovary syndrome – is there any connection between these two conditions through leptin – a twin study. Med. J. Malaysia. 2005;60:441–446
  28. Landén M, Baghaei F, Rosmond R, Holm G, Björntorp P, Eriksson E. Dyslipidemia and high waist-hip ratio in women with self-reported social anxiety. Psychoneuroendocrinology. 2004;29:1037–1046
  29. Legro RS. Polycystic ovary syndrome: the new millenium. Mol. Cell Endocrinol. 2001;184:87–93
  30. Lindén-Hirschberg A, Naessén S, Stridsberg M, Byström B, Holte J. Impaired cholecystokinin secretion and disturbed appetite regulation in women with polycystic ovary syndrome. Gynecol. Endocrinol. 2004;19:79–87
  31. Martinez-Bermejo E, Luque-Ramirez M, Escobar-Morreale HF. Obesity and the polycystic ovary syndrome. Minerva Endocrinol. 2007;32:129–140
  32. Matsuoka Y, Nishi D, Nakajima S, Kim Y, Homma M, Otomo Y. Incidence and prediction of psychiatric morbidity after a motor vehicle accident in Japan: the Tachikawa Cohort of motor vehicle accident study. Crit. Care Med. 2008;36:74–80
  33. McCluskey S, Evans C, Lacey JH, Pearce JM, Jacobs H. Polycystic ovary syndrome and bulimia. Fertil. Steril. 1991;55:287–291
  34. McCluskey SE, Lacey JH, Pearce JM. Binge-eating and polycystic ovaries. Lancet. 1992;340:723
  35. Michelmore KF, Balen AH, Dunger DB. Polycystic ovaries and eating disorders: are they related?. Hum. Reprod. 2001;16:765–769
  36. Naessen S, Carlstrom K, Bystrom B, Pierre Y, Hirschberg AL. Effects of an antiandrogenic oral contraceptive on appetite and eating behavior in bulimic women. Psychoneuroendocrinology. 2007;32:548–554
  37. Naessen S, Carlstrom K, Garoff L, Glant R, Hirschberg AL. Polycystic ovary syndrome in bulimic women—an evaluation based on the new diagnostic criteria. Gynecol. Endocrinol. 2006;22:388–394
  38. Ovesen PG, Moller N, Greisen S, Ingerslev HJ. Polycystic ovary syndrome I. Clinical presentation and treatment. Ugeskr Laeger. 1998;160:260–264
  39. Pan A, Ye X, Franco OH, Li H, Yu Z, Zou S, et al. Insulin resistance and depressive symptoms in middle-aged and elderly Chinese: findings from the nutrition and health of aging population in China study. J. Affect. Disord. 2007;
  40. Papakostas GI. Limitations of contemporary antidepressants: tolerability. J. Clin. Psychiatry. 2007;68(Suppl. 10):11–17
  41. Papakostas GI, Petersen T, Iosifescu DV, Burns AM, Nierenberg AA, Alpert JE, et al. Obesity among outpatients with major depressive disorder. Int. J. Neuropsychopharmacol. 2005;8:59–63
  42. Raphael FJ, Rodin DA, Peattie A, Bano G, Kent A, Nussey SS, et al. Ovarian morphology and insulin sensitivity in women with bulimia nervosa. Clin. Endocrinol. (Oxf.). 1995;43:451–455
  43. Rasgon NL, Rao RC, Hwang S, Altshuler LL, Elman S, Zuckerbrow-Miller J, et al. Depression in women with polycystic ovary syndrome: clinical and biochemical correlates. J. Affect. Disord. 2003;74:299–304
  44. Roberts RE, Deleger S, Strawbridge WJ, Kaplan GA. Prospective association between obesity and depression: evidence from the Alameda County Study. Int. J. Obes. Relat. Metab. Disord. 2003;27:514–521
  45. Rosenfield RL. Clinical review: identifying children at risk for polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 2007;92:787–796
  46. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group . Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil. Steril. 2004;81:19–25
  47. Seidell JC, Cigolini M, Deurenberg P, Oosterlee A, Doornbos G. Fat distribution, androgens, and metabolism in nonobese women. Am. J. Clin. Nutr. 1989;50:269–273
  48. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The mini-international neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J. Clin. Psychiatry. 1998;59(Suppl. 20):22–33quiz 34–57
  49. Simon GE, Von Korff M, Saunders K, Miglioretti DL, Crane PK, van Belle G, et al. Association between obesity and psychiatric disorders in the US adult population. Arch. Gen. Psychiatry. 2006;63:824–830
  50. Sundblad C, Bergman L, Eriksson E. High levels of free testosterone in women with bulimia nervosa. Acta Psychiatrica Scandinavica. 1994;90:397–398
  51. Sundblad C, Landén M, Eriksson T, Bergman L, Eriksson E. Effects of the androgen antagonist flutamide and the serotonin reuptake inhibitor citalopram in bulimia nervosa: a placebo-controlled pilot study. J. Clin. Psychopharmacol. 2005;25:85–88
  52. Timonen M, Laakso M, Jokelainen J, Rajala U, Meyer-Rochow VB, Keinanen-Kiukaanniemi S. Insulin resistance and depression: cross sectional study. Bmj. 2005;330:17–18
  53. Urbanek M. The genetics of the polycystic ovary syndrome. Nat. Clin. Pract. Endocrinol. Metab. 2007;3:103–111
  54. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J. Clin. Endocrinol. Metab. 1999;84:3666–3672
  55. Weber B, Lewicka S, Deuschle M, Colla M, Heuser I. Testosterone, androstenedione and dihydrotestosterone concentrations are elevated in female patients with major depression. Psychoneuroendocrinology. 2000;25:765–771
  56. Weiner CL, Primeau M, Ehrmann DA. Androgens and mood dysfunction in women: comparison of women with polycystic ovarian syndrome to healthy controls. Psychosom. Med. 2004;66:356–362
  57. Winokur A, Maislin G, Phillips JL, Amsterdam JD. Insulin resistance after oral glucose tolerance testing in patients with major depression. Am. J. Psychiatry. 1988;145:325–330

PII: S0306-4530(08)00154-6

doi: 10.1016/j.psyneuen.2008.06.003

Psychoneuroendocrinology
Volume 33, Issue 8 , Pages 1132-1138 , September 2008

Article Tools